Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Market Cap	$429.15M	P/E Ratio	16.04
52W High	$10.91	52W Low	$6.47
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-96.0%	52W Position	45.8%
Overall Score	50	Value Score	60
Quality Score	--	Technical Score	40

EPS Current Est	$0.53	EPS Next Est	$0.48
EPS Growth Est	-9.4%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EHAB	$8.50	+4.81%	576.14K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EHAB	$8.50	+4.8%	576.14K
3
4
5
6

EHAB

EHAB

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Enhabit Inc. Data in Excel

Get Enhabit Inc. Data in Excel